On September 26, 2019, Veeva Systems, a leader in cloud-based software for the global life sciences industry, and Crossix Solutions, a leader in privacy-safe patient data and analytics, announced that they have entered into a definitive agreement for Veeva to acquire Crossix, which will operate as an independent business unit under its current brand led by Crossix CEO Asaf Evenhaim. Wilson Sonsini Goodrich & Rosati is representing Veeva Systems in the transaction.

Veeva Systems, headquartered in Pleasanton, California, serves more than 775 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Crossix Solutions partners with health brands to maximize media and marketing effectiveness through robust data analytics; their patented Crossix SafeMine and Crossix DIFA technologies support customers which include top 20 pharma companies, leading health systems, pharmacies, and other wellness brands. The merger is anticipated to close in November 2019.

The Wilson Sonsini team representing Veeva Systems in the transaction includes partners Melissa Hollatz, John McGaraghan, Madeleine Boshart, Myra Sutanto Shen, Matt Staples, and Richard Blake; senior counsels Christopher Williams and Todd Hahn; and associates Brendan Mahan, Matthew Baudler, Erin Malone-Shkurkin, Mark Cornillez-Ty, Daniel Chen, and Matt Gorman.

For more information, please see Veeva Systems and Crossix Solutions' press release.